Maria Trapero-Marugan

Summary

Publications

  1. pmc Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin
    Maria Trapero-Marugan
    Gastroenterology Hepatology Department, University Hospital La Princesa and Princesa Research Institute, Autonomous University of Madrid and CIBERehd, C Diego de Leon 62, Madrid, Spain
    World J Gastroenterol 17:493-8. 2011
  2. doi request reprint Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment
    M Trapero-Marugan
    Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, Autonomous University of Madrid, and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    J Clin Pharm Ther 36:695-703. 2011
  3. ncbi request reprint Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center
    M Trapero-Marugan
    Gastroenterology and Hepatology Department, Hospital Universitario de la Princesa, Autonomous University of Madrid, Spain
    J Chemother 19:423-7. 2007
  4. ncbi request reprint Treatment regimens for patients with chronic hepatitis C
    M Trapero-Marugan
    Digestive Diseases Department and CIBEREHD, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    Minerva Gastroenterol Dietol 54:209-17. 2008
  5. ncbi request reprint Combined antiviral options for the treatment of chronic hepatitis C
    Jesus Medina
    Unidad de Hepatología planta 3, Hospital Universitario de la Princesa, Universidad Autonoma, Diego de Leon 62, E 28006 Madrid, Spain
    Antiviral Res 60:135-43. 2003
  6. doi request reprint Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin
    M Trapero-Marugan
    Gastroenterology Hepatology Service and CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Aliment Pharmacol Ther 28:468-74. 2008
  7. ncbi request reprint Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy
    J Mendoza
    Service of Digestive Diseases and CIBERehd, University Hospital La Princesa, Universidad Autonoma, Madrid, Spain
    Rev Esp Enferm Dig 102:426-34. 2010
  8. doi request reprint Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature
    Maria Chaparro
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Crohns Colitis 7:e61-5. 2013
  9. ncbi request reprint Is interferon-beta an alternative treatment for chronic hepatitis C?
    Ricardo Moreno-Otero
    Unit of Hepatology, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    World J Gastroenterol 12:2730-6. 2006
  10. ncbi request reprint The colorectal carcinoma prognosis factors. Significance of diagnosis delay
    E Gómez-Domínguez
    Service of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Rev Esp Enferm Dig 98:322-9. 2006

Collaborators

Detail Information

Publications15

  1. pmc Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin
    Maria Trapero-Marugan
    Gastroenterology Hepatology Department, University Hospital La Princesa and Princesa Research Institute, Autonomous University of Madrid and CIBERehd, C Diego de Leon 62, Madrid, Spain
    World J Gastroenterol 17:493-8. 2011
    ..To assess the clinical, biochemical and virological long-term outcome in chronic hepatitis C (CHC) patients with a sustained virological response (SVR) after peginterferon (PEG-IFN) plus ribavirin combination therapy...
  2. doi request reprint Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment
    M Trapero-Marugan
    Gastroenterology and Hepatology Service, Hospital Universitario de la Princesa, Autonomous University of Madrid, and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    J Clin Pharm Ther 36:695-703. 2011
    ..Our objective was to assess the efficacy, safety and predictive factors for sustained virological response (SVR) to peginterferon plus ribavirin in chronic hepatitis C patients who failed to interferon-alfa (IFNα)-based therapy...
  3. ncbi request reprint Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center
    M Trapero-Marugan
    Gastroenterology and Hepatology Department, Hospital Universitario de la Princesa, Autonomous University of Madrid, Spain
    J Chemother 19:423-7. 2007
    ..In conclusion, the lower stage of fibrosis, lower viremia and higher SVR rate than genotype 1 suggest a less aggressive pattern of diseased caused by this genotype...
  4. ncbi request reprint Treatment regimens for patients with chronic hepatitis C
    M Trapero-Marugan
    Digestive Diseases Department and CIBEREHD, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    Minerva Gastroenterol Dietol 54:209-17. 2008
    ....
  5. ncbi request reprint Combined antiviral options for the treatment of chronic hepatitis C
    Jesus Medina
    Unidad de Hepatología planta 3, Hospital Universitario de la Princesa, Universidad Autonoma, Diego de Leon 62, E 28006 Madrid, Spain
    Antiviral Res 60:135-43. 2003
    ....
  6. doi request reprint Predictive graphical model, network-based medical tool for the prognosis of chronic hepatitis C patients treated with peg-interferon plus ribavirin
    M Trapero-Marugan
    Gastroenterology Hepatology Service and CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Aliment Pharmacol Ther 28:468-74. 2008
    ..There are few model networks to predict treatment outcome in viral hepatitis...
  7. ncbi request reprint Hepatic fibrosis in patients with chronic hepatitis C assessed by transient elastography: implications for determining the efficacy of antiviral therapy
    J Mendoza
    Service of Digestive Diseases and CIBERehd, University Hospital La Princesa, Universidad Autonoma, Madrid, Spain
    Rev Esp Enferm Dig 102:426-34. 2010
    ..The efficacy of combination therapy with peginterferon plus ribavirin to eradicate viral infection in patients with chronic hepatitis C (CHC) is well established; moreover, it is able to arrest or even reverse liver fibrosis...
  8. doi request reprint Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature
    Maria Chaparro
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Crohns Colitis 7:e61-5. 2013
    ..Surveillance for colorectal cancer should be strongly recommended in this group of patients...
  9. ncbi request reprint Is interferon-beta an alternative treatment for chronic hepatitis C?
    Ricardo Moreno-Otero
    Unit of Hepatology, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain
    World J Gastroenterol 12:2730-6. 2006
    ..It might be worth assessing the value of IFNbeta plus ribavirin in randomized studies with a larger cohort of patients, not eligible or not tolerating standard therapy, and for non-responders...
  10. ncbi request reprint The colorectal carcinoma prognosis factors. Significance of diagnosis delay
    E Gómez-Domínguez
    Service of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Rev Esp Enferm Dig 98:322-9. 2006
    ..The aim of this study was to establish whether a delay in diagnosis or other factors are related to CRC stage...
  11. doi request reprint Evaluation of liver fibrosis by transient elastography in methotrexate treated patients
    Almudena Barbero-Villares
    Servicio de Aparato Digestivo y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Med Clin (Barc) 137:637-9. 2011
    ....
  12. ncbi request reprint Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis
    Ricardo Moreno-Otero
    Service of Digestive Diseases and Ciberehd Planta 3, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Diego de Leon 62, 28006 Madrid, Spain
    Curr Drug Saf 6:197-200. 2011
    ..A complete remission was achieved in this patient with corticosteroids therapy...
  13. ncbi request reprint [Hepatic disease in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease)]
    Rosario Gonzalez-Casas
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Espana
    Med Clin (Barc) 129:629-31. 2007
  14. pmc Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma
    Paloma Sanz-Cameno
    Laboratory of Investigation, Molecular Biology Unit, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, 28006 Madrid, Spain
    J Oncol 2010:272170. 2010
    ....
  15. pmc Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase
    R Moreno-Otero
    Gut 55:1055-6. 2006